SCHEMBL28617984

SCHEMBL28617984

CCCCCCCCCCCCC(Oc1ccc2ccccc2c1)C(=O)O

nearest known ligand 0.79

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 10/20 0.79
▸ PPARG P37231 9/20 0.79
▸ CTRC Q99895 1/20 0.58
▸ PTGES O14684 1/20 0.55
▸ ALOX5 P09917 1/20 0.55
▸ CETP P11597 1/20 0.54
▸ ALDH2 P05091 1/20 0.49
▸ FOLH1 Q04609 1/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ PTPN7 P35236 1/20 0.44
▸ EPHX1 P07099 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1565456 0.94 PPARG (0.83) PPARAPPARGCTRCPTGESALOX5
SCHEMBL15903011 0.87 CTRC (0.64) PPARAPPARGCTRCPTGESALOX5
SCHEMBL28763254 0.87 CTRC (0.64) PPARAPPARGCTRCPTGESALOX5
SCHEMBL7553803 0.87 CTRC (0.64) PPARAPPARGCTRCPTGESALOX5
SCHEMBL570688 0.87 CTRC (0.64) PPARAPPARGCTRCPTGESALOX5
SCHEMBL4001414 0.87 CTRC (0.64) PPARAPPARGCTRCPTGESALOX5
SCHEMBL22828775 0.87 CTRC (0.64) PPARAPPARGCTRCPTGESALOX5
SCHEMBL6342298 0.87 CTRC (0.64) PPARAPPARGCTRCPTGESALOX5
SCHEMBL11531304 0.87 CTRC (0.64) PPARAPPARGCTRCPTGESALOX5
SCHEMBL4002165 0.87 CTRC (0.64) PPARAPPARGCTRCPTGESALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113214329-A Preparation method of Lipid X and intermediate thereof, and intermediate thereof 上海医药工业研究院 2021-08-06 — — CN disclosed
CN-113214335-A Lipid X intermediate and preparation method thereof 上海医药工业研究院 2021-08-06 — — CN disclosed
Send feedback